Database : HANSEN
Search on : ANEMIA HEMOLITICA [Subject descriptor]
References found : 7 [refine]
Displaying: 1 .. 7   in format [Detailed]

page 1 de 1

  1 / 7 HANSEN  
              next record last record
select
to print
Id:18103
Author:Desforges, J. F; Thayer, W. W; Dawson, J. P
Title:Hemolytic anemia induced by sulfoxone therapy, with investigations into the mechanisms of its production ?-
Source:Boston; s.n; 1960. 5p p. ilus.
Abstract:A case report is presented of a patient in whom clinical evidence of hemolytic anemia with methemoglobinemia developed upon increasing the dosage of sulfoxone which he was receiving for Hansen's disease. Administration of the drug was withdrawn for six weeks, after which studies were made with the use of radioactive iron to demosntrate the hemolytic effect of sulfoxone. By means of tagging cells of a single age group, it was shown that the suceptibility to hemolysis was related to cell age, and it was only after the red cells had been in the circulation for approximately fifty days that they were subject to the hemolytic effects of this drug. No significant biochemical defect could be demonstrated in the erythrocytes of this patient. However, the decline in activity of glucose-6-phosphate dehydrogenase and glutathione reductase in the aging red cell and the reported sensitivity to this drug of patients with red cell deficiency of glucose-6-phosphate dehydrogenase suggest that the hemolytic mechanism is related to this enzyme system. The case demonstrates that drug-induced hemolytic anemia of this type may occur without demonstrable enzymatic defect of the erythrocytes. The observation that patients appear to compensate for the hemolytic anemia and methemoglobinemia if maintained on this drug may be explained by the fact that the older cells containing less adequate enzyme systems are removed from the circulation and an equilibrium is maintained by increased production of red cells with a shorter age span.
Descriptors:HANSENOSTATICOS/admin
HANSENOSTATICOS/ef adv
HANSENOSTATICOS/sangue
HANSENOSTATICOS/uso terap
ANEMIA HEMOLITICA/ind quim
ANEMIA HEMOLITICA/diag
ANEMIA HEMOLITICA/etiol
HANSENIASE/clas
 HANSENIASE/compl
 HANSENIASE/diag
 HANSENIASE/terap
Limits:RELATO DE CASO
Location:BR191.1; 00720/s


  2 / 7 HANSEN  
              first record previous record next record last record
select
to print
Id:13444
Author:Tomecki, Kenneth J; Catalano, Charles J
Title:Dapsone hypersensitivity ..-
Source:s.l; s.n; jan. 1981. 2 p. .
Abstract:A hypersensitivity reaction to low-dose (50-mg), short-term dapsone administration developed in a 16-year-old girl. The reaction included fever, malaise, dermatitis, jaundice with hepatic dysfunction, lymphadenopathy, and hemolytic anemia. Physicians should be familiar with this sulfone syndrome, an uncommon, potentially serious, side effect of dapsone therapy.(AU).
Descriptors:ACNE VULGAR/quimioter
ANEMIA HEMOLITICA/etiol
DAPSONA/ef adv
ERUPCAO POR DROGA/etiol
HIPERSENSIBILIDADE A DROGAS/diag
HEPATITE TOXICA/etiol
DOENCAS LINFATICAS/ind quim
SINDROME
Limits:RELATO DE CASO
HUMANO
FEMININO
ADOLESCENTE
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 00741/s


  3 / 7 HANSEN  
              first record previous record next record last record
select
to print
Id:13263
Author:Tomecki, Kenneth J; Catalano, Charles J
Title:Dapsone hypersensitivity ..-
Source:s.l; s.n; jan. 1981. 2 p. .
Abstract:A hypersensitivity reaction to low-dose (50-mg), short-term dapsone administration developed in a 16-year-old girl. The reaction included fever, malaise, dermatitis, jaundice with hepatic dysfunction, lymphadenopathy, and hemolytic anemia. Physicians should be familiar with this sulfone syndrome, an uncommon, potentially serious, side effect of dapsone therapy.(AU).
Descriptors:ACNE VULGAR/quimioter
ANEMIA HEMOLITICA/etiol
DAPSONA/ef adv
ERUPCAO POR DROGA/etiol
HIPERSENSIBILIDADE A DROGAS/diag
HEPATITE TOXICA/etiol
DOENCAS LINFATICAS/ind quim
SINDROME
Limits:RELATO DE CASO
HUMANO
FEMININO
ADOLESCENTE
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 00724/s


  4 / 7 HANSEN  
              first record previous record next record last record
select
to print
Id:13243
Author:Kenner, D. J; Holt, K; Agnello, R; Chester, G. H
Title:Permanent retinal damage following massive dapsone overdose ..-
Source:s.l; s.n; oct. 1980. 4 p. ilus, graf.
Abstract:A massive dose of 7.5 g of 4,4'-diamino, diphenyl sulphone (dapsone) taken as a suicide attempt in a patient on long-term therapy for tuberculoid leprosy resulted in permanent bilateral retinal necrosis, previously unreported side effect of this drug. The patient developed a severe haemolytic anaemia, methaemoglobinaemia, and acute renal failure requiring peritoneal dialysis. It is proposed that the retinal damage was due to a combination of severe hypoxaemia and the physical effects of red cell fragmentation producing vascular occlusion in the macular and perimacular region, with consequent ischaemic necrosis...(AU).
Descriptors:ANEMIA HEMOLITICA/ind quim
ANGIOFLUORESCEINOGRAFIA
INSUFICIÊNCIA RENAL AGUDA/ind quim
MACULA LUTEA
METEMOGLOBINEMIA/ind quim
DAPSONA/env
NECROSE
DOENCAS RETINIANAS/ind quim
TENTATIVA DE SUICIDIO
Limits:RELATO DE CASO
HUMANO
MASCULINO
ADULTO
Electronic Medium:http://www.ilsl.br
Location:BR191.1; 00677/s


  5 / 7 HANSEN  
              first record previous record next record last record
select
to print
Id:9588
Author:Malfara, Wilson Roberto
Title:Efeito de antagonistas de receptores H2 na metemoglobinemia induzida pela dapsona em ratos ?-
Source:Ribeirao Preto; s.n; 2000. 114 p. ilus, tab, graf.
Thesis:Present for Universidade de Sao Paulo. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto presented for the degree Mestre.
Abstract:Dapsona, farmaco bacteriostatico utilizado no tratamento da hanseniase, vem sendo associado a intercorrencias clinicas, principalmente devido a sua hemotoxicidade. A N-hidroxilacao, uma das principais vias de biotransformacao da dapsona vem sendo associada constantemente a quadros de metemoglobinemia decorrentes do uso da dapsona. Com objetivo de se verificar a inibicao reversivel desta via de bioativacao toxicologica, sem alterar os caminhos de detoxificacao do farmaco, a aceltilacao citosolica, a cimetidina, ranitidina e famotidina foram administradas concomitantemente a dapsona em ratos machos Wistar, com peso variando entre 200 e 250g divididos em 30 grupos (n=6), em estudo de doses unicas e multiplas. Apos as administracoes, os ratos foram submetidos a coleta de sangue(AU).
Descriptors:HANSENIASE
DAPSONA
ANEMIA HEMOLITICA
CIMETIDINA
CROMATOGRAFIA LIQUIDA
ANALISE ESTATISTICA
TOXICOLOGIA
METEMOGLOBINEMIA
Location:BR191.1; WC335.102, M294e


  6 / 7 HANSEN  
              first record previous record next record last record
select
to print
Id:9353
Author:Kulkarni, A. G
Title:Treatment of leprosy ..-
Source:s.l; s.n; 1992. 1 p. .
Descriptors:ANEMIA HEMOLITICA
CLOROQUINA
DEFICIENCIA DE GLUCOFOSFATO DESIDROGENASE
HANSENIASE
HANSENIASE
Location:BR191.1; 06447/s


  7 / 7 HANSEN  
              first record previous record
select
to print
Id:3659
Author:Ramanujam, K; Smith, Michael
Title:Haemolytic anaemia during treatment of leprosy with diaminodiphenylsulphone by mouth ..-
Source:s.l; s.n; 1951. 2 p. .
Descriptors:HANSENIASE
ANEMIA HEMOLITICA
Location:BR191.1; 02498/s



page 1 de 1
   


Refine the search
  Database : HANSEN Advanced form   
Search for : Free form   

    Search in field  
1  
2
3
 
           



Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO
Latin American and Caribbean Center on Health Sciences Information